Trial intelligence / Profile preview

Pilot pharmacokinetic comparison of Envarsus vs Advagraf under fasting vs fed conditions in stable kidney transplant recipients

2017-004450-41Phase 4Active

Sponsor
Parc de Salut Mar
Start
Jan 2018
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of tacrolimus in kidney allograft rejection (2 arms), sponsored by Parc de Salut Mar. Started Jan 2018; status: active.

02

Drugs

tacrolimus
03

Conditions

kidney allograft rejection

Beyond the preview

Go deeper on 2017-004450-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-004450-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call